Cargando…

Golgi phosphoprotein 2 (GOLPH2) is a novel bile acid-responsive modulator of oesophageal cell migration and invasion

BACKGROUND: The aetiology of Barrett's oesophagus (BO) and oesophageal cancer is poorly understood. We previously demonstrated that Golgi structure and function is altered in oesophageal cancer cells. A Golgi-associated protein, GOLPH2, was previously established as a tissue biomarker for BO. C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Byrne, Anne-Marie, Bekiaris, Spiros, Duggan, Gina, Prichard, David, Kirca, Murat, Finn, Stephen, Reynolds, John V, Kelleher, Dermot, Long, Aideen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815786/ https://www.ncbi.nlm.nih.gov/pubmed/26461057 http://dx.doi.org/10.1038/bjc.2015.350

Ejemplares similares

Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway
por: Liu, Hongying, et al.
Publicado: (2018)

GOLPH3L antagonizes GOLPH3 to determine Golgi morphology
por: Ng, Michelle M., et al.
Publicado: (2013)

Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition
por: Wen, Yu, et al.
Publicado: (2019)

GOLPH3 keeps the Golgi residents at home
por: Lowe, Martin
Publicado: (2021)

GOLPH3 and GOLPH3L are broad-spectrum COPI adaptors for sorting into intra-Golgi transport vesicles
por: Welch, Lawrence G., et al.
Publicado: (2021)

GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics
por: Kristiansen, G, et al.
Publicado: (2008)

Golgi phosphoprotein 2 in physiology and in diseases
por: Kim, Ha-Jeong, et al.
Publicado: (2012)

GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma
por: Xue, Y, et al.
Publicado: (2014)

The GOLPH3 pathway regulates Golgi shape and function and is activated by DNA damage
por: Buschman, Matthew D., et al.
Publicado: (2015)

Golgi-Related Proteins GOLPH2 (GP73/GOLM1) and GOLPH3 (GOPP1/MIDAS) in Cutaneous Melanoma: Patterns of Expression and Prognostic Significance
por: Donizy, Piotr, et al.
Publicado: (2016)

The Golgi Localization of GOLPH2 (GP73/GOLM1) Is Determined by the Transmembrane and Cytoplamic Sequences
por: Hu, Longbo, et al.
Publicado: (2011)

Increased circulating cell signalling phosphoproteins in sera are useful for the detection of pancreatic cancer
por: Takano, S, et al.
Publicado: (2010)

The multiple cellular functions of the oncoprotein Golgi phosphoprotein 3
por: Sechi, Stefano, et al.
Publicado: (2015)

Independent duplications of the Golgi phosphoprotein 3 oncogene in birds
por: Opazo, Juan C., et al.
Publicado: (2021)

GOLPH3 drives cell migration by promoting Golgi reorientation and directional trafficking to the leading edge
por: Xing, Mengke, et al.
Publicado: (2016)

Golgi Apparatus Target Proteins in Gastroenterological Cancers: A Comprehensive Review of GOLPH3 and GOLGA Proteins
por: Bucurica, Sandica, et al.
Publicado: (2023)

Expression of Osteopontin in oesophageal squamous cell carcinoma
por: Kita, Y, et al.
Publicado: (2006)

Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer
por: Liu, Yiming, et al.
Publicado: (2021)

Golgi Phosphoprotein 3 Regulates the Physical Association of Glycolipid Glycosyltransferases †
por: Ruggiero, Fernando M., et al.
Publicado: (2022)

A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma
por: Wang, Yigang, et al.
Publicado: (2015)

Golgi Oncoprotein GOLPH3 Gene Expression Is Regulated by Functional E2F and CREB/ATF Promoter Elements
por: Peñalver-González, Beatriz, et al.
Publicado: (2019)

Knockdown of Golgi phosphoprotein 2 inhibits hepatocellular carcinoma cell proliferation and motility
por: Liu, Yiming, et al.
Publicado: (2016)

Unconjugated secondary bile acids activate the unfolded protein response and induce golgi fragmentation via a src-kinase-dependant mechanism
por: Sharma, Ruchika, et al.
Publicado: (2016)

Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma
por: Yuen, H-F, et al.
Publicado: (2007)

The characterization of an intestine-like genomic signature maintained during Barrett’s-associated adenocarcinogenesis reveals an NR5A2-mediated promotion of cancer cell survival
por: Duggan, Shane P., et al.
Publicado: (2016)

Corrigendum: The characterization of an intestine-like genomic signature maintained during Barrett’s-associated adenocarcinogenesis reveals an NR5A2-mediated promotion of cancer cell survival
por: Duggan, Shane P., et al.
Publicado: (2016)

Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma
por: Mimura, K, et al.
Publicado: (2005)

Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma
por: Maruyama, T, et al.
Publicado: (2010)

Curcumin induces apoptosis-independent death in oesophageal cancer cells
por: O'Sullivan-Coyne, G, et al.
Publicado: (2009)

MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma
por: Fisher, O M, et al.
Publicado: (2015)

Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma
por: Yamasaki, M, et al.
Publicado: (2011)

Golgi phosphoprotein 3 sensitizes the tumour suppression effect of gefitinib on gliomas
por: Wang, Xu, et al.
Publicado: (2019)

Diagnostic Utility of Serum Golgi Phosphoprotein 3 in Bladder Cancer Patients
por: Lu, Jianlei, et al.
Publicado: (2019)

Hypoxia-associated markers in gastric carcinogenesis and HIF-2α in gastric and gastro-oesophageal cancer prognosis
por: Griffiths, E A, et al.
Publicado: (2008)

Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma
por: Tuynman, J B, et al.
Publicado: (2008)

Oesophageal adenocarcinoma is associated with a deregulation in the MYC/MAX/MAD network
por: Boult, J K R, et al.
Publicado: (2008)

Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy
por: Yoshikawa, R, et al.
Publicado: (2008)

Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma
por: Komatsu, S, et al.
Publicado: (2011)

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer
por: Kelly, P, et al.
Publicado: (2012)

siRNA Library Screening Identifies a Druggable Immune-Signature Driving Esophageal Adenocarcinoma Cell Growth
por: Duggan, Shane P., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_odumh2li0r0f9roakka9u9jd8a